An ESC statement on gender differences in medical care and survival after myocardial infarction
A paper published online by the journal Circulation on 8 December 2008 concluded that, while men and women have a similar in-hospital death rate following acute myocardial infarction, women with STEMI had an adjusted mortality rate almost twice as high as men (10.2% versus 5.5%). These differenc...
The ESC launches a new release of HeartScore
A new release of HeartScore the interactive tool designed to predict and help manage the risk of heart attack and stroke in Europe created by the European Society of Cardiology (ESC) was launched on Tuesday 18 November 2008 at www.HeartScore.org .
This revised version includes relative risk fo...
Collaborative use of Imaging Techniques proved effective in Cardiovascular Diagnosis – ESC Recommend
Patient undergoing multiple tests to diagnose and investigate cardiovascular diseases was being the current trend and which seemed to be promoted //by advanced imaging modalities.
The European Society of Cardiology (ESC) has recommended that an inter-disciplinary collaboration of various imagin...
Implanted defibrillators: New recommendations for drivers with ICDs
A team of twelve experts from the European Heart Rhythm Association (EHRA), the Council on Cardiovascular Nursing and Allied Professions in esc
(CCNAP) and the Section Cardiac Rehabilitation of the European Association of Cardiovascular Prevention and Rehabilitation, reviewed the literature, a...
Big disparities in the treatment of arrhythmias across Europe
...o compile data on the current situation in various esc
membership countries, compare them, and propose ac...very different.
Data shows big differences across esc
member countries in:
Guideline implementation...ns" highlights Prof Wolpert.
"Within the Non-EU esc
member countries, there has been a steady increase...
ESC Congress 2009: World's biggest cardiology meeting to be held in Barcelona
...ions and practical take home messages, not to mention reports on the latest esc
Prevention and risk factor identification is the special the...ench to bedside track and a special abstract session.
For the first time esc
2009 will offer the opportunity for delegates to gain hands-on image and de...
Telemonitoring changes the working practice of cardiac nurses
...d health professionals," says Professor Christi Deaton, Chair person of the esc
Council on Cardiovascular Nursing and Allied Professions (CCNAP).
Mary ...s then passed through the catheter, and inflated to reopen the artery. Both esc
and American guidelines have identified primary angioplasty as the 'gold st...
Microsoft Windows Embedded Announces Winner of SPARKs Will Fly Developer Contest
...ir devices during the Microsoft industry address given by Windows Embedded General Manager, Kevin Dallas, on Tuesday, March 31. Following the address, esc
attendees were invited to select the winner by voting for the device of their choice at the Microsoft booth. The third finalist withdrew his participa...
Edmond Scientific Company Demonstrates RHIO/HIE Data Security and Privacy Solution for the NHIN at Annual HIMSS Conference, Chicago '09
...Department of Defense, and has since applied those skills to both the litigation support and health informatics sectors. For more information about esc
or the HIMSS demonstration, please contact Mary O'Donnell at (703)766-3871, ext: 330, or email firstname.lastname@example.org " target="_new"> modonnell@e...
Samplify Rolls Production Quantities of Its SAM1600 Analog/Digital Converters with Real-Time Data Compression
... IP or software. A complete ADC evaluation board with data analysis software is also available now for $1,995.00.
See the SAM1600 Family at esc
Samplify will exhibit its SAM1600 family March 31- April 2 during the Embedded Systems Conference, Booth 2131, at the McEnery Conven...
ESC in Medical Technology
FDA Submission of B-R-A-H-M-S MR-proANP Kryptor
...stically challenging subgroups such as obesity, higher age or renal
dysfunction compared to routinely used markers.
First presented at the 2008 esc
Congress and subsequently at the 2008 AHA
annual meeting, the results of the BACH-trial confirm the company's
commitment to improving healthcare throu...
New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients
... -Data Published in 'The Lancet' and Presented at esc
PHILADELPHIA, Sept. 4 /PRNewswire/ -- Results from a new international
study, the GISSI Heart Failure (GISSI-HF) study, showed that 1 g/d ...
Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
...5 months) in 13,608 acute coronary syndromes (ACS)
patients who were managed with PCI. New or recurrent heart attacks were
classified according to the esc
Universal Definition of Myocardial
Infarction as spontaneous (Type 1) or procedure-related (Type 4 or 5).(1)
The analysis showed that prasugrel consis...
Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
...gein, Netherlands at the European Society of
Cardiology (ESC) congress. One of the world's most prestigious scientific
meetings for cardiologists, the esc
meetings took place from August 30 -
September 3 in Munich, Germany.
Dr. Boersma's first study involved 45 patients with paroxysmal atrial
n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure
... MUNICH - esc
Congress 2008, September 2 /PRNewswire-FirstCall/ --
- Presented at the Annual esc
Congress 2008, Munich, Germany, 31 August
during a Solvay-sponsored symposium at esc
2008. He commented. "Very
recently, we have seen a...
TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated With Second-Generation TAXUS(R) Liberte(R) Stent
... Larry Neumann 508-650-8696 (office) Investor Relations Boston Scientific Corporation
On site at esc
Natacha Gassenbach (508) 250-9348 (mobile) Media relations Boston Scientific
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008
...wledge of PCI use and help inform physicians as
to appropriate treatment options for the sickest patients."
Details of the Company's activities at esc
2008 are below.
Schedule of events (all times are Munich time)
Monday, September 1 -- SYNTAX Study data. One-year outcomes data from the SYNTAX t...
Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
...ing late and
very late stent thrombosis out to five years," said Prof. Sigmund Silber,
M.D., F.A.C.C., F.E.S.C., who presented the TAXUS II results at esc
"In this trial, the data revealed that the TAXUS paclitaxel-eluting stent
maintained its efficacy benefits and had no thrombosis between years f...
Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
...rik Jorgensen, M.D., from The
Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark, the
investigator who presented the results at the esc
Congress. "It is also
important to note that at five years, the long-term safety of the CYPHER(R)
Stent was comparable to the bare metal stent arm of ...
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
data will further reinforce the safety and efficacy of its
second-generation drug-eluting stent system. Details of the Company's activities at esc
2007 are below.
Schedule of events (all times are Vienna time)
Sunday, September 2
-- OLYMPIA Phase II & III one-year data. Preliminary results...
ESC in Biological Technology
Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007
EBAC-Accredited Workshop Set for Sept. 3
UPPSALA, Sweden and WILMINGTON, Mass., Aug. 31 /PRNewswire/ -- Nico
Pijls, M.D., Ph.D., and Bernard de Bruyne, M.D., Ph.D., will present the
benefits of measuring coronary pressure, or Fractional Flow Reserve (FFR),
in improving the outc...
Sanofi-aventis Announces Second Quarter 2009 Results
...of the ACTIVE-A study.
In addition, the results of various studies are due to be presented shortly at medical congresses:
(European Society of Cardiology) - Barcelona, August 29 through September 2
Results of the CURRENT/OASIS-7 study, evaluating a new therapeut...
Repair Stem Cell Institute Warns About Real Cost of Embryonic Stem Cell Research
...argolis pointed out that just five days before the esc
announcement, Dr. Bernadine Healy, former director...that the scientist who first isolated and cultured esc
once said 'embryonic stem cells are not being used...ble with RSC is rapidly approaching 200, while the esc
count still sits on zero, despite the efforts of a...
Kelly Osbourne and International Health Groups Call for Improved Education on Choices and Usage of Contraception
EUROPEAN SOCIETY OF CONTRACEPTION AND REPRODUCTIVE HEALTH (ESC)
was founded in France in 1988 and is a leading medical society
in the field...uctive health care internationally. In order to
achieve its objectives, the esc
strives to harmonize the legal situation
internationally and to promote ava...
ApoA-I Data Presented at European Society of Cardiology Congress
...ts atherosclerosis cardiovascular disease," stated Dr. Jan
Johansson, Senior Vice President Medical Affairs Resverlogix. Johansson
further added, "The esc
is a well regarded scientific meeting as well as
one of the largest with an estimated 25,000 participants. We are pleased to
have presented our data t...
Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery
... Media Relations Boston Scientific Corporation
Larry Neumann 508-650-8696 (office) Investor Relations Boston Scientific Corporation
On site at esc
Natacha Gassenbach (508) 250-9348 (mobile) Media Relations Boston Scientific
Geraldine Varoqui (49) 170-782-85-58 (mobile) Media Re...
With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Treatment Shown to Reduce Myocardial Infarction (Heart Attack) and Revascularisation in Stable Coronary Patients
...L study: a step further in title Coronary Artery Disease
Hotline Title: The BEAUTIFUL study: efficacy of session title ... artery disease and left ventricular dysfunction
Hotline 31st August 2008, 11:18 - 11:31 AM session time